Triple
T19157450
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Propecia |
E468960
|
entity |
| Predicate | sharesActiveIngredientWith |
P40775
|
FINISHED |
| Object | Proscar |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Proscar | Statement: [Propecia, sharesActiveIngredientWith, Proscar]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Proscar Context triple: [Propecia, sharesActiveIngredientWith, Proscar]
-
A.
Propecia
Propecia is a brand-name prescription medication (finasteride) primarily used to treat male pattern hair loss.
-
B.
Sicalis
Sicalis is a genus of small, brightly colored Neotropical finches in the tanager family Thraupidae.
-
C.
Lethenteron
Lethenteron is a genus of jawless, eel-like lampreys found primarily in freshwater and coastal regions of the Northern Hemisphere.
-
D.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
E.
Acomplia
Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Proscar Target entity description: Proscar is a brand-name prescription medication containing finasteride, primarily used to treat benign prostatic hyperplasia (enlarged prostate) in men.
-
A.
Propecia
Propecia is a brand-name prescription medication (finasteride) primarily used to treat male pattern hair loss.
-
B.
Sicalis
Sicalis is a genus of small, brightly colored Neotropical finches in the tanager family Thraupidae.
-
C.
Lethenteron
Lethenteron is a genus of jawless, eel-like lampreys found primarily in freshwater and coastal regions of the Northern Hemisphere.
-
D.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
E.
Acomplia
Acomplia is the brand name for rimonabant, a cannabinoid receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dd084ff48190ac0f8c46ee722629 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5eeba91a081909c04d61d6117da06 |
completed | April 20, 2026, 9:15 a.m. |
Created at: April 10, 2026, 12:06 p.m.